The use of cannabidiol (CBD) as an analgesic component.
作者信息
Petersen Kristian Kjær-Staal, Rice Andrew S C, Arendt-Nielsen Lars
机构信息
Faculty of Medicine, Department of Health Science and Technology, Center for Neuroplasticity and Pain, Aalborg University, Aalborg, Denmark.
Department of Materials and Production, Center for Mathematical Modeling of Knee Osteoarthritis (MathKOA), Aalborg University, Aalborg, Denmark.
出版信息
Lancet Reg Health Eur. 2023 Nov 14;35:100791. doi: 10.1016/j.lanepe.2023.100791. eCollection 2023 Dec.
Abstract
摘要
相似文献
1
The use of cannabidiol (CBD) as an analgesic component.
Lancet Reg Health Eur. 2023 Nov 14;35:100791. doi: 10.1016/j.lanepe.2023.100791. eCollection 2023 Dec.
2
Can cannabidiol have an analgesic effect?
Fundam Clin Pharmacol. 2024 Feb;38(1):33-41. doi: 10.1111/fcp.12947. Epub 2023 Aug 16.
3
Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties.
Cannabis Cannabinoid Res. 2022 Dec;7(6):804-813. doi: 10.1089/can.2021.0050. Epub 2021 Dec 24.
4
Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles.
Molecules. 2023 May 24;28(11):4299. doi: 10.3390/molecules28114299.
5
Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Na1.8 Channels.
J Neurosci. 2021 Jul 28;41(30):6371-6387. doi: 10.1523/JNEUROSCI.3216-20.2021. Epub 2021 Jun 15.
6
Development of Pure Certified Reference Material of Cannabidiol.
Molecules. 2024 Feb 20;29(5):921. doi: 10.3390/molecules29050921.
7
A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.
Br J Clin Pharmacol. 2022 Jan;88(1):347-355. doi: 10.1111/bcp.14973. Epub 2021 Jul 23.
8
Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism.
Nitric Oxide. 2024 May 1;146:1-9. doi: 10.1016/j.niox.2024.02.005. Epub 2024 Feb 29.
9
Effects of Cannabidiol and a Novel Cannabidiol Analog against Tactile Allodynia in a Murine Model of Cisplatin-Induced Neuropathy: Enhanced Effects of Sub-Analgesic Doses of Morphine.
Med Cannabis Cannabinoids. 2018 Jun 12;1(1):54-59. doi: 10.1159/000489077. eCollection 2018 Jun.
10
Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue.
Nutrients. 2022 May 18;14(10):2101. doi: 10.3390/nu14102101.
引用本文的文献
1
L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.
Biomolecules. 2024 Aug 26;14(9):1065. doi: 10.3390/biom14091065.
本文引用的文献
1
Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
Lancet Reg Health Eur. 2023 Nov 10;35:100777. doi: 10.1016/j.lanepe.2023.100777. eCollection 2023 Dec.
2
Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms.
J Pain. 2024 Apr;25(4):833-842. doi: 10.1016/j.jpain.2023.10.009. Epub 2023 Oct 18.
3
Placebo Response and Media Attention in Randomized Clinical Trials Assessing Cannabis-Based Therapies for Pain: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Nov 1;5(11):e2243848. doi: 10.1001/jamanetworkopen.2022.43848.
4
Predicting pain after standard pain therapy for knee osteoarthritis - the first steps towards personalized mechanistic-based pain medicine in osteoarthritis.
Scand J Pain. 2022 Aug 22;23(1):40-48. doi: 10.1515/sjpain-2022-0082. Print 2023 Jan 27.
5
The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-A randomized, double-blind, placebo-controlled, crossover study.
Eur J Pain. 2022 Sep;26(8):1650-1664. doi: 10.1002/ejp.1988. Epub 2022 Jun 13.
6
Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.
Pain. 2022 Jun 1;163(6):1206-1214. doi: 10.1097/j.pain.0000000000002466. Epub 2021 Aug 27.
7
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies.
Pain. 2021 Jul 1;162(Suppl 1):S5-S25. doi: 10.1097/j.pain.0000000000002268.
8
Presenting the outputs of the IASP Presidential Task Force on Cannabis and Cannabinoid Analgesia.
Pain. 2021 Jul 1;162(Suppl 1):S3-S4. doi: 10.1097/j.pain.0000000000002210.
9
Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials.
Pain. 2021 Jul 1;162(Suppl 1):S45-S66. doi: 10.1097/j.pain.0000000000001929.
10
Mechanistic pain profiling as a tool to predict the efficacy of 3-week nonsteroidal anti-inflammatory drugs plus paracetamol in patients with painful knee osteoarthritis.
Pain. 2019 Feb;160(2):486-492. doi: 10.1097/j.pain.0000000000001427.
Zotero 插件